How much is the latest price of osimertinib in 2024

Osimertinib, a drug that has been marketed in China and is included in medical insurance, has brought new hope to many patients with non-small cell lung cancer. At present, the latest market price of this drug is about five to six thousand yuan, and patients can easily consult and purchase it at the pharmacy of the local hospital.

In addition to domestic original drugs, formal and legal generic drugs of osimertinib also exist in Laos and Bangladesh. The ingredients of these generic drugs are basically the same as those of the original drugs, but the price ranges from a few hundred to one to two thousand yuan. For patients who need overseas versions of generic drugs, it is crucial to choose a formal overseas purchasing channel. This can ensure the authenticity and safety of the drugs and avoid threats to patients' health caused by purchasing counterfeit and substandard drugs.

Osimertinib plays an important role in the treatment of non-small cell lung cancer. It is primarily used to help prevent a certain type of non-small cell lung cancer from coming back after surgery to remove the tumor in adults, providing patients with longer disease-free survival. It is also the treatment of choice for certain types of non-small cell lung cancer in adults that have spread to other parts of the body. Osimertinib has also shown significant therapeutic effects in certain non-small cell lung cancers that have spread to other sites and cannot be successfully treated with similar chemotherapy drugs.

Osimertinib belongs to the kinase inhibitor class of drugs, which effectively prevents the reproduction of cancer cells by blocking the action of abnormal proteins. Not only does this mechanism help stop or slow the spread of cancer cells, it may also help shrink tumors, giving patients more opportunities for treatment and longer survival.